This Article Figures Only Full Text Full Text (PDF) View CVN News Brief Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (3) Citing Articles via Google Scholar Google Scholar Articles by Kelbæk, H. Articles by Thuesen, L. Search for Related Content PubMed Articles by Kelbæk, H. Articles by Thuesen, L.

CLINICAL RESEARCH: INVASIVE CARDIOLOGY

Randomized Comparison of Distal Protection Versus Conventional Treatment in Primary Percutaneous Coronary Intervention

The Drug Elution and Distal Protection in ST-Elevation Myocardial Infarction (DEDICATION) Trial

Henning Kelbæk, MD^_*, Christian J. Terkelsen, MD, Steffen Helqvist, MD^_*, Jens F. Lassen, MD, Peter Clemmensen, MD^_*, Lene Kløvgaard, RN^_*, Anne Kaltoft, MD, Thomas Engstrøm, MD^_*, Hans E. Bøtker, MD, Kari Saunamäki, MD^_*, Lars R. Krusell, MD, Erik Jørgensen, MD^_*, Hans-Henrik T. Hansen, MD^_*, Evald H. Christiansen, MD, Jan Ravkilde, MD, Lars Køber, MD^_*, Klaus F. Kofoed, MD^_* and Leif Thuesen, MD^,_*

^_* Department of Cardiology and Cardiac Catheterization Laboratory, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark
Department of Cardiology, Aarhus University Hospital, Skejby, Denmark.

Manuscript received August 16, 2007; revised manuscript received October 10, 2007, accepted October 22, 2007.

^_* Reprint requests and correspondence: Dr. Leif Thuesen, Department of Cardiology, Aarhus University Hospital, Skejby 8200 Aarhus N, Denmark. (Email: leif.thuesen{at}ki.au.dk).

Objectives: The purpose of this study was to evaluate the use of distal protection during percutaneous coronary intervention (PCI) for ST-segment elevation myocardial infarction (STEMI) in native coronary vessels.

Background: Embolization of material from the infarct-related lesion during PCI may result in impaired myocardial perfusion and worsen the prognosis. Previous attempts to protect the microcirculation during primary PCI have had conflicting results.

Methods: We randomly assigned 626 patients with STEMI referred within 12 h to have PCI performed with (n = 312) or without (n = 314) distal protection. The primary end point was complete (70%) ST-segment resolution detected by continuous ST-segment monitoring. Blood levels of troponin-T and creatine kinase-MB were monitored before and after the procedure, and echocardiographic determination of the left ventricular wall motion index (WMI) was performed before discharge.

Results: Patients were well matched in terms of demographic and angiographic baseline characteristics. There was no significant difference in the occurrence of the primary end point (76% vs. 72%, p = 0.29), no difference in maximum troponin-T (4.8 µg/l and 5.0 µg/l, p = 0.87) or maximum creatine kinase-MB (185 µg/l and 184 µg/l, p = 0.99), and no difference in median WMI (1.70 vs. 1.70, p = 0.35). The rate of major adverse cardiac and cerebral events (MACCE) 1 month after PCI was 5.4% with distal protection and 3.2% with conventional treatment (p = 0.17).

Conclusions: The routine use of distal protection by a filterwire system during primary PCI does not seem to improve microvascular perfusion, limit infarct size, or reduce the occurrence of MACCE (Drug Elution and Distal Protection During Percutaneous Coronary Intervention in ST Elevation Myocardial Infarction; NCT00192868 [ClinicalTrials.gov] ).

Abbreviations and Acronyms   ECG = electrocardiogram   MACCE = major adverse cardiac and cerebral events   PCI = percutaneous coronary intervention   STEMI = ST-segment elevation myocardial infarction   TLR = target lesion revascularization   WMI = wall motion index

This article has been cited by other articles:

				S. R. Dixon, C. L. Grines, and W. W. O'Neill The year in interventional cardiology. J. Am. Coll. Cardiol., June 2, 2009; 53(22): 2080 - 2097. [Full Text] [PDF]

				M. Busk, A. Kaltoft, S. S. Nielsen, M. Bottcher, M. Rehling, L. Thuesen, H. E. Botker, J. F. Lassen, E. H. Christiansen, L. R. Krusell, et al. Infarct size and myocardial salvage after primary angioplasty in patients presenting with symptoms for <12 h vs. 12-72 h Eur. Heart J., June 1, 2009; 30(11): 1322 - 1330. [Abstract] [Full Text] [PDF]

				A. A. Bavry, D. J. Kumbhani, and D. L. Bhatt Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trials Eur. Heart J., December 2, 2008; 29(24): 2989 - 3001. [Abstract] [Full Text] [PDF]

				C. J. Terkelsen, J. T. Sorensen, and T. T. Nielsen Is There Any Time Left for Primary Percutaneous Coronary Intervention According to the 2007 Updated American College of Cardiology/American Heart Association ST-Segment Elevation Myocardial Infarction Guidelines and the D2B Alliance? J. Am. Coll. Cardiol., October 7, 2008; 52(15): 1211 - 1215. [Abstract] [Full Text] [PDF]